Pathogenesis and treatment of asthma: Recent advances

Drug Discovery Today: Disease Mechanisms

Volumn 1, Issue 1, 2004, Pages 111-116

  Lazaar, Aili L ^a   Panettieri, Reynold A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 (2,6 DICHLOROPHENYL) 2 (2,4 DIFLUOROPHENYLTHIO)PYRIMIDO[1,6 B]PYRIDAZIN 6 ONE; ANTIASTHMATIC AGENT; ANTIINFLAMMATORY AGENT; CILOMILAST; CORTICOSTEROID; IMMUNOGLOBULIN E ANTIBODY; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PKF 241466; PKF 242 484; ROFLUMILAST; S 5751; SAR 943; SB 681323; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ASTHMA; CLINICAL TRIAL; DISEASE COURSE; DISEASE PREDISPOSITION; DRUG EFFICACY; DRUG MECHANISM; GENETIC ASSOCIATION; HUMAN; NONHUMAN; PATHOGENESIS; REVIEW;

EID: 22744436961     PISSN: 17406765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmec.2004.08.003     Document Type: Review

References (44)

1. Raby, B.A. and Weiss, S.T. (2004) ADAM33: where are we now? Am. J. Respir. Cell Mol. Biol. 31, 1-2
2. Wills-Karp, M. and Ewart, S.L. (2004) Time to draw breath: asthma-susceptibility genes are identified. Nat. Rev. Genet. 5, 376-387
3. Barbato, A. et al. (2003) Airway inflammation in childhood asthma. Am. J. Respir. Crit. Care Med. 168, 798-803
4. Payne, D.N. et al. (2003) Early thickening of the reticular basement membrane in children with difficult asthma. Am. J. Respir. Crit. Care Med. 167, 78-82
5. Jenkins, H.A. et al. (2003) Histopathology of severe childhood asthma: a case series. Chest 124, 32-41
6. Woodruff, P.G. et al. (2004) Hyperplasia of smooth muscle in mild/moderate asthma without changes in cell size or gene expression. Am. J. Respir. Crit. Care Med. 169, 1001-1006
7. Schmidt, M. et al. (2003) Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J. Immunol. 171, 380-389
8. Kazi, A.S. et al. (2004) Vascular endothelial growth factor-induced secretion of fibronectin is ERK dependent. Am. J. Physiol. 286, L539-L545
9. Westergren-Thorsson, G. et al. (2002) Correlation between airway responsiveness and proteoglycan production by bronchial fibroblasts from normal and asthmatic subjects. Int. J. Biochem. Cell. Biol. 34, 1256-1267
10. Tufvesson, E. and Westergren-Thorsson, G. (2003) Biglycan and decorin induce morphological and cytoskeletal changes involving signalling by the small GTPases RhoA and Rac1 resulting in lung fibroblast migration. J. Cell. Sci. 116, 4857-4864
11. van den Toorn, L.M. et al. (2001) Airway inflammation is present during clinical remission of atopic asthma. Am. J. Respir. Crit. Care Med. 164, 2107-2113
12. Ward, C. et al. (2002) Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma. Thorax 57, 309-316
13. Chetta, A. et al. (2003) Vascular component of airway remodeling in asthma is reduced by high dose of fluticasone. Am. J. Respir. Crit. Care Med. 167, 751-757
14. Groneberg, D.A. et al. (2002) Expression of respiratory mucins in fatal status asthmaticus and mild asthma. Histopathology 40, 367-373
15. FitzGerald, J.M. et al. (2003) Adjustable maintenance dosing with budesonide/formoterol reduces asthma exacerbations compared with traditional fixed dosing: a five-month multicentre Canadian study. Can. Respir. J. 10, 427-434
16. Amrani, Y. et al. (2001) Interferon-gamma modulates cysteinyl leukotriene receptor-1 expression and function in human airway myocytes. Am. J. Respir. Crit. Care Med. 164, 2098-2101
17. Espinosa, K. et al. (2003) CysLT1 receptor upregulation by TGF-beta and IL-13 is associated with bronchial smooth muscle cell proliferation in response to LTD4. J. Allergy Clin. Immunol. 111, 1032-1040
18. Henderson, W.R. Jr. et al. (2002) A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am. J. Respir. Crit. Care Med. 165, 108-116
19. Yang, G. et al. (2004) Transgenic smooth muscle expression of the human CysLT1 receptor induces enhanced responsiveness of murine airways to leukotriene D4. Am. J. Physiol. 286, L992-L1001
20. Woerly, G. et al. (2003) Peroxisome proliferator-activated receptors alpha and gamma down-regulate allergic inflammation and eosinophil activation. J. Exp. Med. 198, 411-421
21. Patel, H.J. et al. (2003) Activation of peroxisome proliferator-activated receptors in human airway smooth muscle cells has a superior antiinflammatory profile to corticosteroids: relevance for chronic obstructive pulmonary disease therapy. J. Immunol. 170, 2663-2669
22. Ward, J.E. et al. (2004) PPARγ ligands, 15-deoxy-Δ12,14- prostaglandin J2 and rosiglitazone regulate human cultured airway smooth muscle proliferation through different mechanisms. Br. J. Pharmacol. 141, 517-525
23. Fujitani, Y. and Trifilieff, A. (2003) In vivo and in vitro effects of SAR 943, a rapamycin analogue, on airway inflammation and remodeling. Am. J. Respir. Crit. Care Med. 167, 193-198
24. Kumar, R.K. et al. (2003) Inhibition of inflammation and remodeling by roflumilast and dexamethasone in murine chronic asthma. J. Pharm. Exp. Ther. 307, 349-355
25. Goncharova, E.A. et al. (2003) Cyclic AMP-mobilizing agents and glucocorticoids modulate human smooth muscle cell migration. Am. J. Respir. Cell Mol. Biol. 29, 19-27
26. Gamble, E. et al. (2003) Antiinflammatory effects of the phosphodiesterase-4 inhibitor cilomilast (Ariflo) in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 168, 976-982
27. Honda, K. et al. (2003) Prostaglandin D2 reinforces Th2 type inflammatory responses of airways to low-dose antigen through bronchial expression of macrophage-derived chemokine. J. Exp. Med. 198, 533-543
28. Mitsumori, S. et al. (2003) Synthesis and biological activity of various derivatives of a novel class of potent, selective, and orally active prostaglandin D2 receptor antagonists. 1. Bicyclo[2. 2. 1]heptane derivatives. J. Med. Chem. 46, 2436-2445
29. Cataldo, D.D. et al. (2002) Matrix metalloproteinase-9 deficiency impairs cellular infiltration and bronchial hyperresponsiveness during allergen-induced airway inflammation. Am. J. Pathol. 161, 491-498
30. McMillan, S.J. et al. (2004) Matrix metalloproteinase-9 deficiency results in enhanced allergen-induced airway inflammation. J. Immunol. 172, 2586-2594
31. Corry, D.B. et al. (2002) Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiency. Nat. Immunol. 3, 347-353
32. Jain, V.V. et al. (2003) Mucosal immunotherapy with CpG oligodeoxynucleotides reverses a murine model of chronic asthma induced by repeated antigen exposure. Am. J. Physiol. 285, L1137-L1146
33. Taube, C. et al. (2003) Inhibition of complement activation decreases airway inflammation and hyperresponsiveness. Am. J. Respir. Crit. Care Med. 168, 1333-1341
34. Singer, M. et al. (2004) A MARCKS-related peptide blocks mucus hypersecretion in a mouse model of asthma. Nat. Med. 10, 193-196
35. Van Eerdewegh, P. et al. (2002) Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 418, 426-430
36. McIntire, J.J. et al. (2001) Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family. Nat. Immunol. 2, 1109-1116
37. Silverman, E.S. et al. (2004) Transforming growth factor-beta1 promoter polymorphism C-509T is associated with asthma. Am. J. Respir. Crit. Care Med. 169, 214-219
38. Zhang, Y. et al. (2003) Positional cloning of a quantitative trait locus on chromosome 13q14 that influences immunoglobulin E levels and asthma. Nat. Genet. 34, 181-186
39. Allen, M. et al. (2003) Positional cloning of a novel gene influencing asthma from chromosome 2q14. Nat. Genet. 35, 258-263
40. Smit, J.J. et al. (2003) The Sic11a1 (Nramp1) gene controls efficacy of mycobacterial treatment of allergic asthma. J. Immunol. 171, 754-760
41. Gorska, M.M. and Alam, R. (2003) Signaling molecules as therapeutic targets in allergic diseases. J. Allergy Clin. Immunol. 112, 241-250
42. Blease, K. et al. (2003) Emerging treatments for asthma. Expert Opin. Emerg. Drugs 8, 71-81
43. Laping, N.J. et al. (2002) Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542. Mol. Pharm. 62, 58-64
44. Toda, M. et al. (2002) A calcium-activated chloride channel (HCLCA1) is strongly related to IL-9 expression and mucus production in bronchial epithelium of patients with asthma. J. Allergy Clin. Immunol. 109, 246-250